Vast Therapeutics

0 followers


Vast is a preclinical biotechnology company focused on treating the world’s most challenging drug-resistant microbial infections that represent one of the greatest threats to global health, food security, and economic development.

Industries

Employees

11-50

Links

Org chart

Nate Stasko

Collapse
Mark Schoenfisch
Chief Scientific Officer
John Simons
VP, Product Development
Stan Hollenbach
VP, Translational Science

Board & advisors

Chuck Swoboda
Executive Chairman
Michael Knowles
Scientific Advisor
Scott Donaldson
Scientific Advisor
Felix Ratjen
Scientific Advisor
John J. Lipuma
Scientific Advisor
Donald Vandevanter
Scientific Advisor
Kevin Winthrop
Scientific Advisor
Patrick A. Flume
Scientific Advisor